Skip to main content

Mean blastomere diameter may predict clinical pregnancy in long agonist protocol intracytoplasmic sperm injection cycles with single embryo transfer



The main purpose of this study was to investigate the effect of mean blastomere diameter (MBD) on pregnancy rates in in vitro fertilization (IVF) cases undergoing the long agonist cycle protocol. A total of 84 cases were evaluated within the scope of this observational prospective study. All cases were normoresponders, under 35 years old, with the long agonist protocol applied and single embryo (grade I or II) transfer performed. On the third day after ICSI, each embryo selected for transfer was subjected to measurement of the mean blastomere diameter (MBD) at ×25 magnification.


The mean female age was 30.14 ± 3.32 years, and the total clinical pregnancy rate was 33.3%. In the group that got pregnant, MBD was found to be statistically significantly higher than in the nonpregnant group. In terms of predicting clinical pregnancy, when the MBD value of 49.73 μm was accepted as the best cutoff value, the sensitivity was calculated as 75% and specificity as 53.6%. Clinical pregnancy rate was 18.9% in cases below this value, whereas clinical pregnancy rate was 44.7% in cases with this value and above. In other words, when the MBD value rose above 49.73 μm from a value below 49.73 μm, the clinical pregnancy rate increased by an average of 2.3 times.


With MBD measurement, it is possible to select the embryo with the best implantation capability in microinjection cycles with the long luteal agonist protocol.


The intracytoplasmic microinjection process continues to be used as the best option in cases with severe male infertility and in cases where success cannot be achieved in classical in vitro fertilization (IVF) [1]. With this method, compared with the classical IVF method, the stages of attachment to the oocyte membrane by the movement of the sperm, passing through the membrane, and reaching the cytoplasm will be bypassed. According to current data, eliminating these stages by microinjection does not cause serious problems and congenital anomalies in the baby [2,3,4].

From another perspective, it is clear that clinical pregnancy rates will increase in the case of double embryo transfer in pregnancies obtained through assisted reproductive techniques. However, with two-embryo transfer, the live birth rate, the rate of bringing a baby home, decreases and the risk of multiple pregnancy increases [5]. These risks may be reduced by a well-selected single embryo transfer.

Over time, embryologists have developed grading systems to form a common language worldwide to describe embryo morphology. Currently, well-defined embryo assessment criteria that have been used in IVF clinics consist of morphologic features such as fragmentation, symmetry, multi-nucleation, and vacuolation [6].

In the detailed literature search, no study was found on use of the mean blastomere diameter (MBD) to evaluate the morphological features of the third day embryo in ICSI cycles. Based on our experience and preliminary study results, we hypothesized that the mean blastomere diameter (MBD) would be higher in cycles achieving clinical pregnancy.

Hence, the main purpose of this study was to investigate the effect of MBD on pregnancy rates in IVF cases undergoing the long agonist cycle protocol. This would be an appropriate way to choose the best embryo to maximize the clinical pregnancy rate.


A total of 84 cases (86 ICSI cycles) were evaluated within the scope of this observational prospective study. The research period was 14 months, and approval was obtained from the Ethics Committee of Karadeniz Technical University Faculty of Medicine.

All cases were normoresponders, under 35 years old, with the long agonist protocol applied and single embryo (grade I or II [<10% fragmentation] with 8 cells) transfer performed. On the third day after ICSI, each embryo selected for transfer was subjected to measurement of the MBD at × 25 magnification.

The standard luteal long lucrin ovulation induction protocol, details of which were given in our previous study, was applied in all cases [7]. Women with high progesterone (≥0.8 ng/mL) levels on HCG day were excluded.

Egg collection was performed at the 36th h after HCG, microinjection was performed in all cases, fertilization was evaluated 17 h after ICSI, and the presence of 2 PN was confirmed in all cases. ICSI was performed approximately 38 h after HCG triggering. The embryo grading system recommended by Hardarson et al. was used [8]. Day 3 embryo transfer was preferred. Embryo transfer was performed an average of 75 h after ICSI. All patients had single embryo transfer. Embryo transfer was performed by a single clinician (SG) and embryologist under the guidance of ultrasonography. Soft catheter (Wallace, Smith Co., UK) was used for embryo transfer. Type 1 embryo transfer detailed below was performed in all cases. The cases were prepared for embryo transfer under lithotomy position with a full bladder. A sterile Graves speculum was placed, and the cervix was cleaned with saline solution first, then washed with culture solution. No trial transfer was made. The uterus endometrial cavity was visualized by pelvic ultrasonography. The embryo brought with a soft catheter was gently placed 1–2 cm below the fundus under the guidance of ultrasonography. The transfer catheter was removed from the cavity by gently turning it. The fundus was not touched during the embryo transfer. The removed catheter was checked under the microscope for embryo retention, blood, and mucus. No blood or mucus was observed. For luteal phase support, all cases were recommended to use vaginal progesterone gel twice a day in the morning and evening, starting from the day of egg collection until the time of pregnancy test.

All cases had normal sperm parameter values, given below. Sperm volume was above 1.5 mL, sperm count was over 15 million/mL, sperm progressive motility value was above 32%, and sperm morphology was over 4%, according to Tygerberg’s method [9].

On the third day after ICSI, each embryo selected for transfer was subjected to measurement of the MBD at × 25 magnification. MBD was measured after an average of 72 h after ICSI. In all cases, embryos containing only 8 blastomeres were considered within the scope of the study and selected for transfer. Embryos derived from giant oocytes or oocytes with large perivitelline space were not included. Embryos containing more than 20% asymmetric blastomeres were not included in the study. Only one photo showing all blastomeres was selected for MBD measurement. The following procedure was applied for MBD calculation. First, an embryo containing 8 cells, no more than 10% fragmentation, and less than 20% blastomere asymmetry was selected for transfer by the single embryologist. Then, two diameters perpendicular to each blastomere were measured. These two diameters were summed up and divided in half. These measurements were made for every 8 blastomeres. Average values of each blastomere were summed and divided by 8, and the MBD was found in micrometers (Fig. 1). The mean zona thickness was calculated by the following formula: Zona thickness (micrometers) was measured in two different areas around the embryo, summed up, and then divided by two.

Fig. 1
figure 1

Photograph of day 3 embryo showing the measurement of zona thickness in the embryo and mean blastomere diameter in each blastomere

Cases with normoresponder female and normal male evaluation tests were selected according to the study protocol. The same ovarian stimulation protocol was applied. Embryos were evaluated for fertilization and cleavage by a single embryologist (OY, with 10 years of experience in an IVF laboratory). MBD and zona thickness were measured by a single embryologist (OY). This process took an average of 3 min. Day 3 embryo transfer was performed. On the 12th day after the embryo transfer, a pregnancy test was performed in the blood. In cases with a positive pregnancy test, detection of heart rate via transvaginal ultrasound during the follow-up period was accepted as clinical pregnancy.

Clinical pregnancy was defined as an embryo with a heartbeat detected under ultrasonographic evaluation 4 weeks after embryo transfer. Fisher’s exact chi-square test, Student’s t test, and ROC analysis were used for statistical analysis. The SPSS computer program was used for statistical analysis. A p value of less than 0.05 was considered statistically significant. According to our preliminary study results, the MBD was accepted as 49 and a standard deviation of 3.5 in the group that could not conceive, and 52 in the group that did conceive. According to these data, when there were at least 21 cases in each group, alpha was 0.05 and power was calculated as 0.8.


The mean female age in the study group was 30.14 ± 3.32 years. In all cases, the clinical pregnancy rate was 33.3%, and the rate of taking a baby home was 31.0%.

The comparison of clinical and laboratory/embryologic data is given in Table 1. The MBD was found to be statistically significantly higher in the pregnant group (n = 28) compared with the nonpregnant group (n = 56) (52.09 ± 3.98 vs. 49.44 ± 3.62 μm, respectively, p = 0.003, Student’s t test).

Table 1 Comparison of clinical and embryologic characteristics in pregnant and nonpregnant groups

According to the ROC analysis test result, the area under the curve for MBD was 0.680 (95% CI 0.562–0.798) (Fig. 2). In terms of predicting clinical pregnancy, when the MBD value of 49.73 μm was accepted as the best cutoff value, the sensitivity was calculated as 75% and specificity as 53.6%. Clinical pregnancy rate was 18.9% in cases below this value, whereas clinical pregnancy rate was 44.7% in cases with this value and above (p = 0.01, Fisher’s exact chi-square test). In other words, when the MBD value rose above 49.73 μm from a value below 49.73 μm, the clinical pregnancy rate increased by an average of 2.3 times.

Fig. 2
figure 2

Receiver operating characteristic curve to calculate the best MBD value for predicting clinical pregnancy

Similarly, the live birth rate was 23.1% when the MBD was below 49.73, and the live birth rate was 76.9% when the MBD was 49.73 and above (p = 0.008, Fisher’s exact chi-square test). The live birth rate increased 3.3 times when the MBD value increased from below 49.73 to 49.73 and above.


The main goal of this study was to determine the embryo with high adherence potential to the endometrium that would increase the clinical pregnancy rate in ICSI cycles by morphological parameter evaluation. The result clearly showed that MBD higher than 49.73 μm could predict embryos more ideal for transfer, thus increasing the clinical pregnancy rates in ICSI cycles.

Embryo morphology evaluation on day 3 is useful in the determination of the best embryos [10]. In the past, more than two embryos were transferred to increase pregnancy rates. However, it has been found that this approach also increases the rate of multiple pregnancy and poses additional medical risks for the mother and baby [11]. Changing embryo selection criteria over the years has brought innovations in the selection of the best embryo to implant, and the process of recovery in clinical pregnancies and a decrease in multiple pregnancies has started [11, 12]. The risks that develop with the transfer of excess embryos have been included in the relevant scope of international authorities on ART, and many associations have published guidelines on the subject [13]. All these developments have put pressure on IVF centers to transfer a small number, preferably a single embryo. This has led to the intensification of research on the best embryo selection criteria.

Although many morphological evaluation methods related to blastomeres have been defined, the effect of MBD on ART success is still unknown.

In 2003, Johansson et al. studied the DNA content of blastomeres/fragments using donated excess embryos. They included grade 3 embryos, which were defined as >20% but <50% fragments and/or blastomeres/cells of all sizes and/or heavily granulated cytoplasm or vacuolation. According to this study, the blastomere size should be over 45 μm in the second day embryo and over 40 μm in the third day embryo in order to be called a blastomere. They concluded that cells smaller than this were always anucleated and should be considered fragments [14]. This suggests a relationship between the increase in blastomere diameter and impaired development of the embryo. It is possible that this situation will affect pregnancy rates in IVF.

According to the results of the current study published by Gardner et al., low, medium, or high viability classification determined by morphometric evaluation of the embryo is important to the implantation of the embryo and clinical pregnancy rates. Ideal day 3 embryos with high viability are described as the ones with mononucleated blastomeres, equal cell size, <20% fragmentation, and at least 4 blastomeres. Thus, ideal embryos are related to higher implantation, pregnancy, and birth rates [15]. Our study is the first to measure MBD and relate the cutoff value to the clinical pregnancy rate. The researchers concluded that bio- and/or morphokinetic markers are important in the selection of the embryo for transfer, among which morphological data play a key role [15].

Alpha Scientists in Reproductive Medicine and the ESHRE Special Interest Group of Embryology organized a meeting in 2010 in Istanbul. At this meeting, oocyte, zygote, and embryo grading criteria were evaluated in the IVF laboratory, and a consensus was reached [6]. According to this consensus, the embryo is expected to have 4 cells on the second day and 8 cells on the third day, depending on the time of ICSI or IVF. Embryo fragmentation was evaluated as mild when below 10%, moderate when it was 10–25%, and severe when it was above 25%. If the appearance of multinucleation is detected, the implantation potential of the embryo will be low, the rate of chromosomal anomalies will be high, and the rate of spontaneous abortion will be high [6, 15]. Criteria such as blastomere size evaluation, cytoplasmic granularity scoring, membrane appearance scoring, and cytoplasmic vacuole presence grading in the second- or third-day embryo are parameters that can be used in terms of morphometric evaluation. These results were obtained from large series and data from many centers. However, MBD was not defined as a morphometric feature, as in other studies.

According to the results of the study on cases with another single embryo transfer, the effects of parameters such as blastomere volume index, blastomere symmetry index, and mean ovality on the ongoing pregnancy rate were investigated. The third day embryo was evaluated in this context [16]. It was concluded that these parameters, which were established with the help of a computer and determined by special formulas, were not useful in terms of embryo selection criteria [16].

Another question is how important morphometric evaluation before embryo transfer might be or whether multiple evaluations will be required. In a systematic review, Kaser and Racowsky investigated the selection of embryos with a time-lapse monitoring system [17]. In this review, the effects of many morphometric parameters (pronuclear dynamics and morphology, first cytokinesis time, nucleus disappearance time after cleavage, time to reach cleavage phases, cleavage cycle time, time to reach morula, time to reach blastocyst phase, etc.) were investigated. Although many studies have reported that embryos that pass the cleavage stage faster have higher implantation potential, it has been concluded that a single morphokinetic parameter cannot be used to evaluate the embryo with the best implantation potential [17].

There are no studies reporting the relationship between blastomere size and pregnancy rates in IVF. However, of course, we estimate that the pregnancy rate will be high in cases with a high blastomere size, up to a certain limit. As the blastomere size increases, the embryo surface area will also increase. The increase in surface area will also increase the area of interaction between the endometrium and the blastomere surface to be implanted. In this way, pregnancy rates may increase, as there will be a large number of endometrial and embryo receptor interactions.

The most important strength of this study is the selection of the embryo with the best implantation potential using the embryo morphometric measurement to be performed on the day of transfer in cases with single embryo transfer. In this way, an embryo with a high pregnancy rate will be transferred. To our best knowledge, MBD has not previously been proposed as a predictor for ICSI outcome. When an embryo with an MBD measurement greater than 49.73 is selected for transfer, in addition to obtaining a high clinical pregnancy rate, multiple pregnancies and their maternal fetal complications may be prevented.

There are some limitations to present study. In this study, the embryo morphological assessment was individual, dependent, and subjective, and there were no intermittent measurement values [18]. Another limitation is the small number of cases. In addition, although all MBD measurements were made by a single embryologist, diameter markings were made manually. The whole study was built on measurements of blastomeres from a single photo, which means that we may have at least 2 blastomeres with no clear outline. This could have some subjective consequences. For the most objective evaluations, a computer-based system would be helpful.


Our results suggest that a simple morphometric measurement may be a tool for fertility clinics to identify embryos with the greatest implantation potential for single embryo transfer, which would increase the chances of successful outcomes and decrease the risk of multiple births. It is suggested that prospective, randomized controlled trials (RCTs) be performed before use in clinical practice.

Availability of data and materials

All data and material mentioned in manuscript would be available upon request.



Assisted reproduction technologies


Intracytoplasmic sperm injection


Follicle stimulating hormone


Mean blastomere diameter


In vitro fertilization


  1. Palermo GD, Cohen J, Alikani M, Adler A, Rosenwaks Z (1995) Development and implementation of intracytoplasmic sperm injection (ICSI). Reprod Fertil Dev 7(2):211–217; discussion 217-218.

    CAS  Article  PubMed  Google Scholar 

  2. Bonduelle M, Liebaers I, Deketelaere V, Derde MP, Camus M, Devroey P, Van Steirteghem A (2002) Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). Hum Reprod 17(3):671–694.

    Article  PubMed  Google Scholar 

  3. Hourvitz A, Pri-Paz S, Dor J, Seidman DS (2005) Neonatal and obstetric outcome of pregnancies conceived by ICSI or IVF. Reprod BioMed Online 11(4):469–475.

    Article  PubMed  Google Scholar 

  4. Sakkas D (2013) Novel technologies for selecting the best sperm for in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 99(4):1023–1029.

    Article  PubMed  Google Scholar 

  5. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S (2013) Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev 7:CD003416.

    Article  Google Scholar 

  6. Alpha Scientists in Reproductive M, Embryology ESIGo (2011) The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26(6):1270–1283.

    Article  Google Scholar 

  7. Guven S, Kart C, Unsal MA, Yildirim O, Odaci E, Yulug E (2014) Endometrial injury may increase the clinical pregnancy rate in normoresponders undergoing long agonist protocol ICSI cycles with single embryo transfer. Eur J Obstet Gynecol Reprod Biol 173:58–62.

    Article  PubMed  Google Scholar 

  8. Hardarson T, Hanson C, Sjogren A, Lundin K (2001) Human embryos with unevenly sized blastomeres have lower pregnancy and implantation rates: indications for aneuploidy and multinucleation. Hum Reprod 16(2):313–318.

    CAS  Article  PubMed  Google Scholar 

  9. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16(3):231–245.

    Article  PubMed  Google Scholar 

  10. Lan KC, Huang FJ, Lin YC, Kung FT, Hsieh CH, Huang HW, Tan PH, Chang SY (2003) The predictive value of using a combined Z-score and day 3 embryo morphology score in the assessment of embryo survival on day 5. Hum Reprod 18(6):1299–1306.

    Article  PubMed  Google Scholar 

  11. Schieve LA, Peterson HB, Meikle SF, Jeng G, Danel I, Burnett NM, Wilcox LS (1999) Live-birth rates and multiple-birth risk using in vitro fertilization. JAMA 282(19):1832–1838.

    CAS  Article  PubMed  Google Scholar 

  12. De Placido G, Wilding M, Strina I, Alviggi E, Alviggi C, Mollo A, Varicchio MT, Tolino A, Schiattarella C, Dale B (2002) High outcome predictability after IVF using a combined score for zygote and embryo morphology and growth rate. Hum Reprod 17(9):2402–2409.

    Article  PubMed  Google Scholar 

  13. Practice Committee of Society for Assisted Reproductive T, Practice Committee of American Society for Reproductive M (2008) Guidelines on number of embryos transferred. Fertil Steril 90(5 Suppl):S163–S164.

    Article  Google Scholar 

  14. Johansson M, Hardarson T, Lundin K (2003) There is a cutoff limit in diameter between a blastomere and a small anucleate fragment. J Assist Reprod Genet 20(8):309–313.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gardner DK, Balaban B (2016) Assessment of human embryo development using morphological criteria in an era of time-lapse, algorithms and ‘OMICS’: is looking good still important? Mol Hum Reprod 22(10):704–718.

    Article  PubMed  Google Scholar 

  16. Vergouw CG, Al Nofal M, Kostelijk EH, Rooth H, Hompes PG, Schats R, Lambalk CB (2013) The association of the blastomere volume index (BVI), the blastomere symmetry index (BSI) and the mean ovality (MO) with ongoing implantation after single embryo transfer. J Assist Reprod Genet 30(4):587–592.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kaser DJ, Racowsky C (2014) Clinical outcomes following selection of human preimplantation embryos with time-lapse monitoring: a systematic review. Hum Reprod Update 20(5):617–631.

    Article  PubMed  Google Scholar 

  18. Sjoblom P, Menezes J, Cummins L, Mathiyalagan B, Costello MF (2006) Prediction of embryo developmental potential and pregnancy based on early stage morphological characteristics. Fertil Steril 86(4):848–861.

    Article  PubMed  Google Scholar 

Download references


Authors thank E. Odaci, E. Yulug, M. A. Unsal, C. Kart, and O. Yildirim for support and help for performing this study.


The authors report no funding sources.

Author information

Authors and Affiliations



SG thought, planned, analyzed, and conducted the research. ESGG and SAT wrote the article and made the final revisions. The last corrections and adjustments have been made by SG. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Suleyman Guven.

Ethics declarations

Ethics approval and consent to participate

The study protocol was approved by Karadeniz Technical University Faculty of Medicine Ethic Council (Date 03/04/2012, Approval number 2012/26). Written inform consent was obtained from all participants.

Consent for publication

Not applicable.

Competing interests

The authors report no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Guven, S., Alanya Tosun, S. & Guvendag Guven, E.S. Mean blastomere diameter may predict clinical pregnancy in long agonist protocol intracytoplasmic sperm injection cycles with single embryo transfer. Middle East Fertil Soc J 26, 10 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • ART
  • Clinical pregnancy
  • Embryo
  • Mean blastomere diameter